Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sertraline for impulsive violent offenders
ACTRN12613000442707Phase 4Recruiting
- Sponsor
- University of New South Wales
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in impulse control disorder (ICD) and intermittent explosive disorder (IED) comparing Sertraline with Placebo (2 arms). Primary endpoint: Offending behaviour. Started Oct 2013; status: recruiting.
02
Drugs
sertraline
03
Conditions
impulse control disorder (ICD)intermittent explosive disorder (IED)
Beyond the preview
Go deeper on ACTRN12613000442707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000442707.